手机验证
询价列表
暂时没有已询价产品
微信扫一扫分享
分享到新浪微博
分享到丁香园论坛
Vodobatinib
企业认证
点击 QQ 联系
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
K0706
货期:1-2天
MedChemExpress LLC
10 mM * 1 mL/5 mg/10 mg/25 mg/50 mg/100 mg
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1388803-90-4
MCE 国际站:Vodobatinib
产品活性:Vodobatinib (K0706) 是一种有效的第三代,且具有口服活性的 Bcr-Abl1 酪氨酸激酶抑制剂,IC50 为 7 nM。Vodobatinib 对大多数 BCR-ABL1 点突变体具有活性,对 BCR-ABL1T315I 无活性。 Vodobatinib 可用于慢性粒细胞白血病 (CML) 研究。
研究领域:Protein Tyrosine Kinase/RTK
作用靶点:Bcr-Abl
In Vitro: In Ba/F3 cells expressing BCR-ABL1, BCR-ABL1L248V, BCR-ABL1Y253H, or BCR-ABL1E255V, Vodobatinib (K0706; 0-2000 nM) treatment shows potent inhibition of BCR-ABL1 tyrosine autophosphorylation.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Drug Repurposing Compound Library | Cytoskeleton Compound Library | Orally Active Compound Library | Anti-Alzheimer's Disease Compound Library | Anti-Blood Cancer Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Targeted Diversity Library | Rare Diseases Drug Library | Heterocyclic Compound Library | Dasatinib | Nocodazole | Imatinib | Ponatinib | Nilotinib | Bosutinib | Asciminib | Degrasyn | Rebastinib | Olverembatinib | AT9283 | KW-2449 | LXH254 | Bafetinib | DPH | AST 487 | Flumatinib | PD173955 | BV02 | GNF-2 | XL228 | GNF-7 | Cenisertib | GNF-5 | SIAIS178
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
马上登录 或注册,即可保存询价历史